Join
Live feed
·
PRReleasevia Quantisnow
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

ByQuantisnow·Wall Street's wire, on your screen.
FHTX· Foghorn Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FHTX (Foghorn Therapeutics Inc.) and more on Quantisnow.